Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03988959
Other study ID # 110/2/2018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2019
Est. completion date June 1, 2019

Study information

Verified date June 2019
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A case series of patient having mucoepidermoid carcinoma, had standard treatment protocol and surgeries and followup was performed and the patient postoperative quality of life and recurrent rate was recorded


Description:

This case series presents mucoepidermoid carcinoma. Palatal mass was resected with safety margin then immediate opturator inserted; superficial parotidectomy was also done for parotid lesion sparing facial nerve. Post-operative radiotherapy was recommended by pathologist due to evident perineural spread. The patient is tumor free after one year follow-up.

Clinical reports about synchronous multiple salivary tumors are very rare, consequently there is little known about its management and clinical presentation. Presence of one or more risk factor should favor expectation of multiple tumors and mandate examination of all salivary tissues. Each tumor should be diagnosed and treated separately according to its nature and extension.


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date June 1, 2019
Est. primary completion date June 1, 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- patients suffering from salivary gland tumor

Exclusion Criteria:

- healthy patients with no tumors

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
resection of mucoeidermoid carcinoma
Surgical resection parotid with preservation of facial nerve

Locations

Country Name City State
Egypt Ain shams university Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life in grades the quality of life of patients is assessed by visual analogue scale in a scale from 1-10. higher values indicates better quality of life 6 months